REGAN BROWN: Open Payments
NPI 1831524875 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,424 in 145 payments from 15 companies in 2025. Trend: 2023 $9,782 · 2024 $18,293 · 2025 $18,424
Speaker / faculty: $14,400Food & beverage: $2,342Travel & lodging: $1,597Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 44 | $16,553 |
| Janssen Biotech, Inc. | 39 | $659 |
| ABBVIE INC. | 10 | $219 |
| UCB, Inc. | 16 | $199 |
| Regeneron Healthcare Solutions, Inc. | 5 | $193 |
| Organon LLC | 2 | $157 |
| Galderma Laboratories, L.P. | 15 | $153 |
| Incyte Corporation | 3 | $65 |
| PFIZER INC. | 3 | $64 |
| Amgen Inc. | 2 | $49 |
Products named: EBGLYSS, TREMFYA, Bimzelx, DUPIXENT, NEMLUVIO, SKYRIZI, VTAMA, TALTZ.
Industry payments across ID — which companies pay providers there.
